DARS2 is a prognostic biomarker and correlated with immune infiltrates and cuproptosis in lung adenocarcinoma.Xu‐Sheng Liu(Hubei University of Medicine), Zhi‐Jun Pei(Hubei University of Medicine)PubMedJanuary 1, 2023Cited by 15SaveCiteExport RISWatch citationsRelated PapersDown-regulation of MRPS23 inhibits rat breast cancer proliferation and metastasis|Oncotarget|2017|35SLC17A9 Is a Novel Prognostic Biomarker Correlated With Immune Infiltrates in Human Lung Adenocarcinoma and Lung Squamous Cell Carcinoma|Research Square|2021|0